NCT03853512 is a Phase 4 clinical trial of BAY207543 (Bepanthol, Bepantol® Derma Spray) in Skin Recovery, sponsored by Bayer.

Who is sponsoring NCT03853512?

NCT03853512 is sponsored by Bayer.

What drugs are being tested in NCT03853512?

Interventions in NCT03853512: BAY207543 (Bepanthol, Bepantol® Derma Spray), Semisolid vaseline.

What condition does NCT03853512 study?

NCT03853512 studies Skin Recovery.

Is NCT03853512 still recruiting?

NCT03853512 is currently completed. Last updated 11 March 2020.

Last reviewed 2020-03-11 · How we verify

NCT03853512

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After a Peeling in the External Genital Area of Women

Completed Phase 4 Last updated 11 March 2020

What this trial tests

Phase 4 trial testing BAY207543 (Bepanthol, Bepantol® Derma Spray) in Skin Recovery in 33 participants. Completed in 13 March 2019.

Timeline

12 February 2019

Primary endpoint
13 March 2019

13 March 2019

Quick facts

Lead sponsor	Bayer
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	33
Start date	12 February 2019
Primary completion	13 March 2019
Estimated completion	13 March 2019
Sites	1 location across Brazil

Drugs / interventions tested

BAY207543 (Bepanthol, Bepantol® Derma Spray) — full drug profile →
Semisolid vaseline

Conditions studied

Skin Recovery — all drugs for Skin Recovery →

Sponsor

Bayer — full company profile →

Who can join

Adults 18 to 60, female only, with Skin Recovery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure (peeling) in the intimate area of women. After the peeling, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other trials of BAY207543 (Bepanthol, Bepantol® Derma Spray)

Trials testing the same drug.

NCT03853525 — A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After Laser Hair Removal in the · Phase 4 · completed
NCT03853538 — A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering · Phase 4 · completed

Other Bayer trials

Trials by the same sponsor.

NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03853512 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayer
Last refreshed: 11 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03853512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing